0000000000025902

AUTHOR

F Hucke

showing 2 related works from this author

Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

2016

Inhibition of the renin-angiotensin system (RAS) was associated with longer survival in patients with different solid malignancies.The objective of this study was to investigate the effect of RAS inhibitor (RASi) treatment (angiotensin-converting enzyme inhibitors or angiotensin-II-receptor blockers) on survival of patients with hepatocellular carcinoma (HCC).Patients diagnosed with HCC and Child-Pugh A between 1992 and 2013 who received sorafenib, experimental therapy, or best supportive care were eligible for the Vienna cohort. The Mainz cohort included patients with HCC and Child-Pugh A who received sorafenib treatment between 2007 and 2016. The association between RASi and overall survi…

OncologySorafenibmedicine.medical_specialtybusiness.industryGastroenterologyOriginal Articlesmedicine.disease03 medical and health sciences0302 clinical medicineText miningEndocrinologyOncology030220 oncology & carcinogenesisHepatocellular carcinomaInternal medicineRenin–angiotensin systemmedicine030211 gastroenterology & hepatologyIn patientbusinessmedicine.drugUnited European gastroenterology journal
researchProduct

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

2021

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentInternal medicineHepatocellular carcinomamedicineImmunotherapymedicine.diseasebusinessOutcome (game theory)Zeitschrift für Gastroenterologie
researchProduct